DURHAM, N.C. & BURLINGTON, N.C.--(BUSINESS WIRE)--Duke University Medical Center and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the translation of newly discovered biomarkers into widely available clinical tools that can measure individual therapeutic responses, predict disease progression, and evaluate any number of biologic or disease-causing processes.
